NCT00947895View on ClinicalTrials.gov

Efficacy Study of Adrenocorticotropin Hormone to Treat Multiple Sclerosis (MS) Relapses After Sub-responding to an Initial 3 Day Course of Intravenous (IV) Methylprednisolone

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Multiple Sclerosis
Interventions
DRUG

Methylprednisolone

IV 1000 mg daily for 3 days

DRUG

ACTH

IM ACTH 80 mg/day for 5 days.

OTHER

IV placebo

IV placebo (saline) daily for 3 days.

OTHER

IM placebo

IM placebo (saline) daily for 5 days.

Trial Locations (1)

32082

Neurologique Foundation, Inc., Ponte Vedra

Sponsors

Collaborators (1)

Mallinckrodt
All Listed Sponsors
collaborator

Mallinckrodt

INDUSTRY

lead

Neurologique Foundation, Inc.

OTHER